= Discovery stage. (24.37%, 2023)
= Translation stage. (39.50%, 2023)
= Clinically available. (36.13%, 2023)
MSACL 2023 : Hoofnagle

MSACL 2023 Abstract

Self-Classified Topic Area(s): Proteomics
Metrologically Traceable Quantification of Three Apolipoprotein E Isoforms in Cerebrospinal Fluid

Andy Hoofnagle
University of Washington

Andy Hoofnagle, MD, PhD (Presenter)
University of Washington

Presenter Bio: Dr. Hoofnagle's laboratory focuses on the precise quantification of recognized protein biomarkers in human plasma using LC-MRM/MS. In addition, they have worked to develop novel assays for the quantification of small molecules in clinical and research settings. His laboratory also studies the role that the systemic inflammation plays in the pathophysiology of obesity, diabetes, and cardiovascular disease.

Relevant Financial Disclosures (within past 24 months, reported on Feb 27, 2026)
No relevant financial relationship(s) to disclose.
Discussing Products? NO, presenter will NOT present educational content related to products/services of the ineligible company(ies) listed above.
Conflict mitigation NOT REQUIRED.

Abstract

Coming soon ...